|
| |
| Information professionnelle sur Stugeron, Comprim: | JNTL Consumer Health II (Switzerland) GmbH | | | N07CA02 - Cinnarizine | ATC-DDD Version 2016. Source: WHO | | | N07 - Other Nervous System Drugs | This group comprises other nervous system drugs, which cannot be classified in the preceding 2nd levels in ATC group N.
|
| | N07C - Antivertigo Preparations | This group comprises agents mainly used in the treatment of vertigo. See also: A04A - Antiemetics and antinauseants C04AX - Other peripheral vasodilators N02C - Antimigraine preparations N05A - Antipsychotics R06A - Antihistamines for systemic use
| The DDDs are based on treatment of vestibular symptoms.
|
| | N07CA - Antivertigo Preparations | Cinnarizine in combination with diphenhydramine teoclate or dihydroergocristine are classified in N07CA52. Cinnarazine in combination with piracetam is classified in N06BX53.
| The DDD for the N07CA52 refers to cinnarizine and is based on the combination of cinnarizine and diphenhydramine teoclate.
|
| |
|
|
|
|